ACT DMD Update with PTC (February 2014) On February 5, 2014, Dr. Robert Spiegel, Chief Medical Officer at PTC Therapeutics, presented an update about PTC’s Phase 3 study of ataluren, now known as the Ataluren Confirmatory Trial in DMD (ACT DMD). Research & Clinical Trial Webinars,Webinars 11 years ago You may also like 1:00:21 Biglycan (December 2011) 13 years ago Research & Clinical Trial Webinars,Webinars 1:00:38 Fat Embolism Syndrome Following Mild Trauma in Duchenne (December 2011) 13 years ago Care Webinars,Webinars 59:50 Genetic Testing Webinar (November 2011) 13 years ago Care Webinars,Research & Clinical Trial Webinars,Webinars 1:01:55 Direct Access: Dr. Kathryn Wagner, Kennedy Krieger Institute (September 2011) 13 years ago Care Webinars,Research & Clinical Trial Webinars,Webinars «1…232425Page 25 of 25
by: Parent Project Muscular Dystrophy
